Therapeutic drug monitoring of immunosuppressant drugs.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

17 citing papers in PubMed.

1. Neurotoxicity of Calcineurin Inhibitors.Annals of Indian Academy of Neurology · 2025
   Article
2. Population pharmacokinetics of tacrolimus whole blood and peripheral blood mononuclear cell concentrations in stable kidney-transplanted patients.British journal of clinical pharmacology · 2025
   Article
3. The history of uveitis: from antiquity to the present day.Eye (London, England) · 2025
   Review
4. A Validated LC-MS/MS Method for Performing Belatacept Drug Monitoring in Renal Transplantation.Biomedicines · 2023
   Article
5. Current Status Regarding Immunosuppressive Treatment in Patients after Renal Transplantation.International journal of molecular sciences · 2023
   Review
6. Microfluidic nanodevices for drug sensing and screening applications.Biosensors & bioelectronics · 2023
   Article
7. Mechanisms, Pathophysiology and Current Immunomodulatory/Immunosuppressive Therapy of Non-Infectious and/or Immune-Mediated Choroiditis.Pharmaceuticals (Basel, Switzerland) · 2022
   Review
8. Performance of the Dimension TAC assay and comparison of multiple platforms for the measurement of tacrolimus.Journal of clinical laboratory analysis · 2018
   Article
9. On the Slow Diffusion of Point-of-Care Systems in Therapeutic Drug Monitoring.Frontiers in bioengineering and biotechnology · 2015
   Review
10. Alternative matrices for therapeutic drug monitoring of immunosuppressive agents using LC-MS/MS.Bioanalysis · 2015
    Review
11. Mycophenolate mofetil enhances the negative effects of sirolimus and tacrolimus on rat kidney cell metabolism.PloS one · 2014
    Article
12. A review on therapeutic drug monitoring of immunosuppressant drugs.Iranian journal of basic medical sciences · 2011
    Article
13. Mechanisms of clinically relevant drug interactions associated with tacrolimus.Clinical pharmacokinetics · 2002
    Review
14. Immunosuppressive therapy for paediatric transplant patients: pharmacokinetic considerations.Clinical pharmacokinetics · 2002
    Review
15. Methods for clinical monitoring of cyclosporin in transplant patients.Clinical pharmacokinetics · 2000
    Review
16. Target concentration intervention: beyond Y2K.British journal of clinical pharmacology · 1999
    Article
17. Xenogenic Engraftment of Human-Induced Pluripotent Stem Cell-Derived Pancreatic Islet Cells in an Immunosuppressive Diabetic Göttingen Mini-Pig Model.Cell transplantation
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as